A new drug is being trialled at two hospitals in Manchester as part of a nationwide effort to find new treatments for COVID-19.
The Manchester Royal Infirmary (MRI) and Wythenshawe Hospital are taking part in a national research programme exploring different drugs for people hospitalised by coronavirus.
Bemcentinib, a tablet used to treat blood disorders, is one of the drugs being tested on Covid patients at the MRI and Wythenshawe Hospital, part of Manchester University NHS Foundation Trust (MFT).
The study falls under the ACCORD-2 (accelerating Covid-19 research and development), one of several research studies trials taking place at MFT as part of COVID-19 urgent public health research.
Read more on manchestereveningnews.co.uk